Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause

Menopause

Volumn 20, Issue 6, 2013, Pages 631-639

  Bleil, Maria E ^a   Bromberger, Joyce T ^b   Latham, Melissa D ^a   Adler, Nancy E ^a   Pasch, Lauri A ^a   Gregorich, Steven E ^c   Rosen, Mitchell P ^a   Cedars, Marcelle I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c Departments of Preventive Medicine   (United States)

Author keywords

Cardiometabolic risk; Cardiovascular risk; Depression; Menstrual cycle length; Metabolic syndrome.; Ovarian function

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIRTH CONTROL; CARDIOMETABOLIC RISK; DEPRESSION; DRUG THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENTAL HEALTH; OVARY FUNCTION; PARITY; PHYSICAL ACTIVITY; PREMENOPAUSE; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DEPRESSION; ETHNIC GROUPS; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MENSTRUAL CYCLE; METABOLIC SYNDROME X; OVARY; PREMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; WAIST CIRCUMFERENCE;

EID: 84879159930     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31827c5c45     Document Type: Article

References (89)

1. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: The Framingham Heart Study. Stroke 2009;40:1044-1049. PMCID: 2682709.
2. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: Long-term health consequences. Maturitas 2010;65:161-166. PMCID: 2815011.
3. Feng Y, Hong XM, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008;196:590-597. PMCID: 2271121.
4. Parashar S, Reid KJ, Spertus JA, Shaw LJ, Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause 2010; 17:938-945.
5. Colditz G, Willett W, Stampfer M, Rosner B, Speizer F, Hennekens C. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
6. Park HA, Park JK, Park SA, Lee JS. Age, menopause, and cardiovascular risk factors among Korean middle-aged women: The 2005 Korea National Health and Nutrition Examination Survey. J Womens Health 2010; 19:869-876.
7. Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease. J Clin Epidemiol 1997;50:475-479.
8. vander Schouw YT, vander Graaf Y, Steyerberg EW, Eijkemans MJC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714-718.
9. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999;159:1061-1066.
10. Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992;136:408-416.
11. Fioretti F, Tavani A, Gallus S, Franceschi S, La Vecchia C. Menopause and risk of non-fatal acute myocardial infarction: An Italian case-control study and a review of the literature. Hum Reprod 2000;15:599-603.
12. Lin JW, Caffrey JL, Chang MH, Lin YS. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2010;95:4258-4267.
13. Dawson JD, Sonka M, Blecha MB, Lin WJ, Davis PH. Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: The Muscatine Offspring Study. J Am Coll Cardiol 2009;53:2273-2279. PMCID: 2747309.
14. Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adultsVimplications for prevention from the pathobiological determinants of atherosclerosis in youth study. JAMA 1999;281:727-735.
15. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adultsVevidence from intravascular ultrasound. Circulation 2001;103:2705-2710.
16. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116-1121.
17. Kaplan J, Manuck S. Ovarian dysfunction and the premenopausal origins of coronary heart disease. Menopause 2008;15:768-776.
18. Kaplan JR, Manuck SB. Ovarian dysfunction, stress, and disease: A primate continuum. ILAR J 2004;45:89-115.
19. Matthews KA, Santoro N, Lasley B, et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 2006;91:1789-1795.
20. Gorgels W, vanderGraaf Y, Blankenstein MA, Collette HJA, Erkelens DW, Banga JD. Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOM-cohort. J Clin Epidemiol 1997;50:275-281.
21. de Kleijn M, van der Schouw Y, van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: A review of the literature. Maturitas 1999;33:7-36.
22. Solomon C, Hu F, Dunaif A. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87:2013-2017.
23. Punnonen R, Jokela H, Aine R, Teisala K, Salomaki A, Uppa H. Impaired ovarian function and risk factors for atherosclerosis in premenopausal women. Maturitas 1997;27:231-238.
24. Bairey Merz C, Johnson B, Sharaf B. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41:413-419.
25. Gast GCM, Grobbee DE, Smit HA, Bueno-de-Mesquita HB, Samsioe GN, van der Schouw YT. Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes. Fertil Steril 2010;94:2379-2381.
26. Barron ML, Flick LH, Cook CA, Homan SM, Campbell C. Associations between psychiatric disorders and menstrual cycle characteristics. Arch Psychiatr Nurs 2008;22:254-265.
27. Bisaga K, Petkova E, Cheng JF, Davies M, Feldman JF, Whitaker AH. Menstrual functioning and psychopathology in a county-wide population of high school girls. J Am Acad Child Adolesc Psychiatry 2002; 41:1197-1204.
28. Joffe H, Kim DR, Foris JM, et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry 2006;67:297-304.
29. Rowland AS, Baird DD, Long S, et al. Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology 2002; 13:668-674.
30. Pasternak A, Brooks PG. The long-term effects of the Holocaust on the reproductive function of female survivors. J Minim Invasive Gynecol 2007;14:211-217.
31. Whitacre F, Barrera B. War amenorrhea. JAMA 1944;124:399-403.
32. Bethea CL, Centeno ML, Cameron JL. Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol 2008; 38:199-230.
33. Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, Genazzan AR. Functional hypothalamic amenorrhea: Current view on neuroendocrine aberrations. Gynecol Endocrinol 2008;24:4-11.
34. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 2011;41:1879-1888.
35. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of United States adults. Epidemiology 1993;4:285-293.
36. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand 1994;89:77-82.
37. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93:1976-1980.
38. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in menVthe precursors study. Arch Intern Med 1998;158:1422-1426.
39. Penninx B, Beekman ATF, Honig A, et al. Depression and cardiac mortalityVresults from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-227.
40. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaten WW. Depression, psychotropic medication, and risk of myocardial infarction: Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94:3123-3129.
41. Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009;71:266-272.
42. Gaysina D, Pierce M, Richards M, Hotopf M, Kuh D, Hardy R. Association between adolescent emotional problems and metabolic syndrome: The modifying effect of C-reactive protein gene (CRP) polymorphisms. Brain Behav Immun 2011;25:750-758.
43. Pulkki-Raback L, Elovainio M, Kivimaki M, et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study. Health Psychol 2009;28:108-116.
44. Luppino FS, Dortland A, Wardenaar KJ, et al. Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosom Med 2011;73:257-264.
45. Whittaker KS, Krantz DS, Rutledge T, et al. Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation Study. Psychosom Med 2012; 74:263-270.
46. Gordon N. How Does the Adult Kaiser Permanente Membership in Northern California Compare with the Larger Community? Oakland, CA: Kaiser Permanente Division of Research, 2006.
47. Agarwal S, Jacobs DR Jr, Vaidya D, et al. Metabolic syndrome derived from principal component analysis and incident cardiovascular events: The Multi Ethnic Study of Atherosclerosis (MESA) and Health, Aging, and Body Composition (Health ABC). Cardiol Res Pract 2012;2012: 919425.
48. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the Bmetabolic syndrome[ and incidence of type 2 diabetes. Diabetes 2002;51:3120-3127.
49. Hillier TA, Rousseau A, Lange C, et al. Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 2006;49:1528-1535.
50. Kekalainen P, Sarlund H, Pyorala K, Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 1999;22:86-92.
51. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999;100:123-128.
52. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
53. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977;106:203-214.
54. Breslau N. Depressive symptoms, major depression, and generalized anxietyVa comparison of self-reports on CESD and results from diagnostic interviews. Psychiatry Res 1985;15:219-229.
55. Nunnally JC. Psychometric Theory. New York, NY: McGraw-Hill.
56. Radloff LS, Teri L. Use of the Center for Epidemiological StudiesV Depression Scale with older adults. Clinic Gerontol 1986;5:119-136.
57. Blazer DG, Landerman LR, Hays JC, Simonsick EM, Saunders WB. Symptoms of depression among community-dwelling elderly African-American and white older adults. Psychol Med 1998;28:1311-1320.
58. Clark VA, Aneshensel CS, Frerichs RR, Morgan TM. Analysis of effects of sex and age in response to items on the CES-D Scale. Psychiatry Res 1981;5:171-181.
59. Hertzog C, Van Alstine J, Usala P, Hultsch D, Dixon R. Measurement properties of the Center for Epidemiological Studies Depression Scale (CES-D) in older populations. Psychol Assess 1990;2:64-72.
60. Knight RG, Williams S, McGee R, Olaman S. Psychometric properties of the Centre for Epidemiologic Studies Depression Scale (CES-D) in a sample of women in middle life. Behav Res Ther 1997;35:373-380.
61. van Rooij IAJ, Broekmans FJM, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 2005; 83:979-987.
62. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
63. Weenen C, Laven JSE, von Bergh ARM, et al. Anti-Mullerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.
64. Visser JA, Themmen APN. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;234:81-86.
65. GruijtersMJG, Visser JA, Durlinger ALL, Themmen APN. Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003; 211:85-90.
66. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-175.
67. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril 2011;95:747-750.
68. Broer S, Eijkemans M, Scheffer G, et al. Anti-Mullerian hormone predicts menopause: A long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011;96:2532-2539.
69. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97:1673-1680.
70. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Mullerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol 2010;150:166-170.
71. Yates A, Rustamov O, Roberts S, et al. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod 2011;26:2353-2362.
72. Fanchin R, Taieb J, Lozano DHM, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923-927.
73. Hehenkamp WJK, Looman CWN, Themmen APN, de Jong FH, te Velde ER, Broekmans FJM. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057-4063.
74. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21:3103-3107.
75. Rustamov O, Pemberton PW, Roberts SA, et al. The reproducibility of serum anti-Mullerian hormone in subfertile women: Within and between patient variability. Fertil Steril 2011;95:1185-1187.
76. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 2008;90:395-400.
77. Deb S, Campbell BK, Pincott-Allen C, Clewes JS, Cumberpatch G, Raine-Fenning NJ. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Mullerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012;39:574-580.
78. Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE. Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51-59.
79. Nelson SM, La Marca A. The journey from the old to the new AMH assay: How to avoid getting lost in the values. Reprod Biomed Online 2011;23:411-420.
80. Jacobs DR, Ainsworth BE, Hartman TJ, Leon AS. A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc 1993;25:81-91.
81. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
82. Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health Across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 2004;89:2622-2631.
83. Rubba F, Mattiello A, Chiodini P, et al. Menstrual cycle length, serum lipids and lipoproteins in a cohort of Italian Mediterranean women: Findings from Progetto ATENA. Nutr Metab Carbiovasc Dis 2008; 18:659-663.
84. Bleil ME, Adler NE, Pasch LA, et al. Psychological stress and reproductive aging among pre-menopausal women. Hum Reprod 2012; 27:2720-2728.
85. Bleil ME, Adler NE, Pasch LA, et al. Depressive symptomatology, psychological stress, and ovarian reserve: A role for psychological factors in ovarian aging? Menopause 2012;19:1176-1185.
86. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: Toward a more precise definition. Menopause 2000;7:334-349.
87. Van Voorhis BJ, Santoro N, Harlow S, Crawford SL, Randolph J. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 2008;112:101-108.
88. Raikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: Antecedent or consequence? Metabolism 2002;51:1573-1577.
89. Pan A, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012;35:1171-1180.